Rajeev Muni
Co-founder & Chief Executive Officer, Vitreoretinal Surgeon Dragonfleye Therapeutics, University of Toronto
Seminars
Thursday 29th January 2026
Panel Discussion: Emerging Device Modalities for Non-Invasive & Precision-Controlled Ocular Drug Delivery
4:30 pm
- Introduce device strategies that expand access to therapies for earlier-stage disease or preventive care
- Explore non-surgical delivery routes using devices that achieve precise spatial control with minimal invasiveness
- Examine how smart implants, responsive polymers, and controlled microfluidic pumps can usher in next-generation, refillable platforms
- Discuss the engineering that remain for these novel approaches to reach the clinic
